Ceramide Cream in Treating Women With Cutaneous Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

January 31, 2001

Primary Completion Date

April 30, 2002

Study Completion Date

October 31, 2009

Conditions
Breast Cancer
Interventions
DRUG

ceramide

Trial Locations (13)

55905

Mayo Clinic Cancer Center, Rochester

57709

Rapid City Regional Hospital, Rapid City

58122

CCOP - Merit Care Hospital, Fargo

58501

Medcenter One Health System, Bismarck

61801

CCOP - Carle Cancer Center, Urbana

68131

CCOP - Missouri Valley Cancer Consortium, Omaha

85259-5404

CCOP - Scottsdale Oncology Program, Scottsdale

52403-1206

CCOP - Cedar Rapids Oncology Project, Cedar Rapids

50309-1016

CCOP - Iowa Oncology Research Association, Des Moines

51101-1733

Siouxland Hematology-Oncology, Sioux City

67214-3882

CCOP - Wichita, Wichita

43623-3456

CCOP - Toledo Community Hospital Oncology Program, Toledo

57105-1080

CCOP - Sioux Community Cancer Consortium, Sioux Falls

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Alliance for Clinical Trials in Oncology

OTHER

NCT00008320 - Ceramide Cream in Treating Women With Cutaneous Breast Cancer | Biotech Hunter | Biotech Hunter